Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

New Gene May Explain Most Breast Cancers

May Offer Screening, Treatment for Women Without Family History of Disease

WebMD Health News

Oct. 7, 2002 -- Cancer researchers have discovered a new gene that may be to blame for most breast cancers. The discovery of the gene -- missing in 60% of breast cancer tumors -- could one day lead to new treatments, according to researchers.

Dubbed DBC2, for "deleted in breast cancer," it's one of a class of genes known as "tumor suppressors," which, when functioning normally, prevent the wild proliferation of abnormal cells associated with cancer. This particular gene, and its biological pathway, has never been identified before.

DBC2 may be particularly important because it's one of a very few genes to be implicated in the 90% of breast cancers characterized as "sporadic" -- afflicting women without any family history of the disease.

Only 10% of breast cancers occur in women with a strong family history of the disease. The best-known and best-understood genes previously identified as abnormal in breast cancer, BRCA1 and BRCA2, appear to be involved primarily in inherited disease.

Currently, no genetic tests can help identify women at increased risk for sporadic breast cancer, but the identification of genes like DBC2 may improve prospects for such tests -- and for new treatments.

Researchers at Cold Spring Harbor Laboratories in New York and at the University of Washington in Seattle, working together, found that the DBC2 gene was turned off in close to 60% of breast cancer tumors, as well as in 50% of lung cancer tumors. In contrast, all samples from normal breast and lung tissue had functioning versions of the DBC2 gene.

When functioning, the DBC2 gene leads to the death of cancer cells or stops them from growing. "When we put a functional version of the gene into a breast cancer cell, then the breast cancer stopped growing. DBC2 clearly has some suppressive function in breast cancer," says lead researcher Masaaki Hamaguchi, MD, PhD.

The results of the DBC2 research will be published Oct. 15 in the Proceedings of the National Academy of Sciences. Tests studying how a normal version of DBC2 affects the growth of lung cancer cells are still ongoing.

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow